Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Abstract The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV). The patients with treatment-naïve mCNV received 1 + PRN intravitreal bevacizumab from March 2008 to F...
Saved in:
Main Authors: | Jia-Kang Wang, Tzu-Lun Huang, Pei-Yao Chang, Yen-Ting Chen, Chin-Wei Chang, Fang-Ting Chen, Yung-Ray Hsu, Yun-Ju Chen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/b1a16bb2849342a8b7df552ffc71a5b3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
by: Korol AR, et al.
Published: (2017) -
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
by: Korol AR, et al.
Published: (2016) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017) -
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
by: Balaratnasingam C, et al.
Published: (2015) -
Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
by: Ryu G, et al.
Published: (2021)